@KexinHuang5 Speed is the first half of the race, and Biomni just set a new record. The real challenge is making sure that data leads to a deliverable product despite IRA and manufacturing hurdles. Exciting times for 'Bio-acc'!"
Speed is useless if you don't finish. π
10x R&D acceleration means nothing if your $100M pipeline hits a "Ghost Factory" or an IRA price wall.
https://t.co/lHkotCMJCV provides the Execution Intelligence (BioMCPβ’) to turn speed into success, not a cliff.
#Bioacc#BioMCP#FoxuAI
@Kekius_Sage "The map of medical innovation is being redrawn globally. π Tracking these dispersed breakthroughs across multiple languages and verifying their IP value in real-time is impossible for humans alone. This is exactly a job for a 24/7 Digital Board. π¦π"
"The era of 'high-margin comfort' in Pharma is over.Medicare price cuts are now reality. CEO's new priority? Zero-based budgeting. Out with $2M consulting bills, in with https://t.co/lHkotCMJCV Digital Executives. 24/7 strategic support at 1/100 the cost.
#BioPharma
@NVIDIAHealth "Moving from pilot to production is the ultimate challenge and opportunity for AI. Can't wait to see the real-world deployment cases at #NVIDIAGTC! π"
Why pay $2M for a "next week" response while pharma margins are under threat? π
Meet https://t.co/lHkotCMJCV BioMCP: Your 24/7 Digital Board. π¦ CSO, IP, & RA expertise at 1/100 the cost. Zero hallucination. No more guessing. π
Stop overpaying for delay. π
#BioMCP#AI#FoxuAI
Give R&D their time back. π§ͺ
With 28k+ new papers daily, manual search is a liability. https://t.co/lHkotCMJCV uses 6 AI agents to turn noise into actionable intelligence. π
Stop guessing. Start knowing.
#Biotech#AI#Pharma#FoxuAI